{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:03:03Z","timestamp":1782540183745,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.mito.2020.11.003","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T06:45:15Z","timestamp":1605768315000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Optical coherence tomography as a possible tool to monitor and predict disease progression in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2795-8430","authenticated-orcid":false,"given":"Akihiro","family":"Shinkai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8583-0171","authenticated-orcid":false,"given":"Yasuhiro","family":"Shinmei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiriko","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-7006","authenticated-orcid":false,"given":"Shinki","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mito.2020.11.003_b0005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.ejhg.5201363","article-title":"LHON\/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation","volume":"13","author":"Blakely","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.mito.2020.11.003_b0010","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41433-017-0010-2","article-title":"Optical coherence tomography in multiple sclerosis","volume":"32","author":"Britze","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.mito.2020.11.003_b0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.iae.0000236468.33325.74","article-title":"Quantification of photoreceptor layer thickness in normal eyes using optical coherence tomography","volume":"26","author":"Chan","year":"2006","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.mito.2020.11.003_b0020","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.jcjo.2015.05.019","article-title":"Retinal nerve fibre layer defect associated with MELAS syndrome","volume":"50","author":"Cho","year":"2015","journal-title":"Can. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.mito.2020.11.003_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2415-14-77","article-title":"Macular dystrophy associated with the mitochondrial DNA A3243G mutation: pericentral pigment deposits or atrophy? Report of two cases and review of the literature","volume":"14","author":"Daruich","year":"2014","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.mito.2020.11.003_b0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3389\/fneur.2017.00701","article-title":"Optical coherence tomography in alzheimer's disease and other neurodegenerative diseases","volume":"8","author":"Doustar","year":"2017","journal-title":"Front. Neurol."},{"issue":"1-2","key":"10.1016\/j.mito.2020.11.003_b0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2020.11.003_b0040","series-title":"Optical Coherence Tomography ESASO Course Series","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000356337","article-title":"Optical Coherence Tomography in the Inner Retinal Layers","author":"Giraud","year":"2014"},{"issue":"1","key":"10.1016\/j.mito.2020.11.003_b0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/13816810.2010.531880","article-title":"Central retinal vein occlusion as the initial manifestation of LHON \/ MELAS overlap syndrome with mitochondrial DNA G13513A mutation\u2014case report and literature review","volume":"32","author":"Hsieh","year":"2011","journal-title":"Ophthalmic Genet."},{"issue":"1-2","key":"10.1016\/j.mito.2020.11.003_b0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mito.2006.11.026","article-title":"Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage","volume":"7","author":"Indo","year":"2007","journal-title":"Mitochondrion"},{"issue":"11","key":"10.1016\/j.mito.2020.11.003_b0055","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s00415-015-7869-2","article-title":"Optical coherence tomography findings in Huntington\u2019s disease: a potential biomarker of disease progression","volume":"262","author":"Kersten","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.mito.2020.11.003_b0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mito.2017.03.006","article-title":"Mitochondrial dysfunction underlying outer retinal diseases","volume":"36","author":"Lefevere","year":"2017","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.mito.2020.11.003_b0065","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/j.jcjo.2017.11.010","article-title":"Transient bilateral optic disc oedema in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)","volume":"53","author":"Mack","year":"2018","journal-title":"Can. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.mito.2020.11.003_b0070","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1167\/iovs.12-9870","article-title":"Wide 3-dimensional macular ganglion cell complex imaging with spectral-domain optical coherence tomography in glaucoma","volume":"53","author":"Morooka","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.mito.2020.11.003_b0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/WNO.0000000000000690","article-title":"Retinal neuronal loss in visually asymptomatic patients with myoclonic epilepsy with ragged-red fibers","volume":"39","author":"Najjar","year":"2019","journal-title":"J. Neuroophthalmol."},{"issue":"6","key":"10.1016\/j.mito.2020.11.003_b0080","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.jcjo.2015.08.021","article-title":"Spectral-domain optical coherence tomography in mitochondrial encephalopathy, lactic acidosis, and strokelike episodes","volume":"50","author":"Navajas","year":"2015","journal-title":"Can. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.mito.2020.11.003_b0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00415-015-7884-3","article-title":"Mitochondrial disease: genetics and management","volume":"263","author":"Ng","year":"2016","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.mito.2020.11.003_b0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0161-6420(95)31032-9","article-title":"Imaging of macular diseases with optical coherence tomography","volume":"102","author":"Puliafito","year":"1995","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.mito.2020.11.003_b0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbabio.2011.10.014","article-title":"LHON\/MELAS overlap mutation in ND1 subunit of mitochondrial complex I affects ubiquinone binding as revealed by modeling in Escherichia coli NDH-1","volume":"1817","author":"P\u00e4tsi","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA) - Bioenergetics"},{"issue":"5","key":"10.1016\/j.mito.2020.11.003_b0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jfo.2019.03.001","article-title":"Glaucoma progression analysis by spectral-domain optical coherence tomography (SD-OCT)","volume":"42","author":"Renard","year":"2019","journal-title":"J. Fran\u00e7ais d'Ophtalmologie"},{"key":"10.1016\/j.mito.2020.11.003_b0105","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0161-6420(13)31404-3","article-title":"Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation","volume":"100","author":"Rummelt","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mito.2020.11.003_b0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/eye.2013.4","article-title":"Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients","volume":"27","author":"Satue","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.mito.2020.11.003_b0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","article-title":"MELAS: a nationwide prospective cohort study of 96 patients in Japan","volume":"1820","author":"Yatsuga","year":"2012","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156772492030204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156772492030204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:26:25Z","timestamp":1761589585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156772492030204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"alternative-id":["S156772492030204X"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2020.11.003","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optical coherence tomography as a possible tool to monitor and predict disease progression in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2020.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and Mitochondria Research Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}